Two patients can be told they are receiving the same treatment and receive products that are not comparable at all. The difference is documented in laboratory paperwork that most patients are never shown. This article explains exactly what to ask for and how to read it.
Why Cell Quality Varies Between Providers
- Donor screening standards differ, and so does the tissue the cells come from
- Culture media and expansion methods are not standardised across laboratories
- Passage limits vary, and some products are expanded well beyond conservative limits
- Release testing may be thorough, minimal, or performed on a different lot entirely
- Cold chain and time to administration affect what actually reaches the patient
None of this is visible in a brochure, which is why the question has to be asked directly. Source differences are compared in UC-MSC versus autologous cells.
The Documents That Actually Prove Quality
- Lot release certificate — specific to the batch you will receive
- Characterisation report — surface markers confirming cell identity
- Sterility and endotoxin results — with test dates, not just a pass claim
- Laboratory accreditation — of the facility that manufactured the lot
- Chain of custody — how the product travelled from laboratory to clinic
Facility standards in Thailand are covered in our article on healthcare and laboratory standards.
A Release Certificate Checklist
| Item | What to look for | Why it matters |
|---|---|---|
| Lot identifier | Matches the vial used on your treatment day | Links the paperwork to your actual dose |
| Cell count and dose | Stated numerically, not described as a package | Makes the treatment reproducible and reviewable |
| Viability | Figure plus the time it was measured | Old measurements do not describe current product |
| Passage number | Within the stated specification limit | Characteristics drift with excessive expansion |
| Identity markers | Positive and negative marker panel reported | Confirms the product is genuinely MSC |
| Safety testing | Sterility, mycoplasma, endotoxin with dates | The core patient-safety requirement |
Ask for this before travel, not on the day, when declining is much harder.
Confirming the Cells Are Genuinely MSCs
- Expression of characteristic markers such as CD73, CD90 and CD105
- Absence of haematopoietic and endothelial markers
- Plastic adherence in culture under standard conditions
- Demonstrated differentiation capacity in validation testing
These are widely used minimal criteria rather than a premium feature. Programme detail is on our MSC therapy page.
Handling, Transport and the Final Hour
- Temperature-controlled transport with a recorded log
- A defined maximum interval between release and administration
- Visual inspection and lot verification against your file at the bedside
- Administration by the planned route, at the planned rate
- Documentation of everything given, filed in your medical record
How this fits into the treatment day is described in our step-by-step MSC therapy walkthrough.
Answers That Should Stop the Conversation
- "Our cells are the highest quality" with no certificate offered
- Dose described only as a package tier rather than a cell count
- Documentation available only after payment
- No named laboratory, or a laboratory that cannot be identified
- Testing results dated well before your lot was prepared
The same standard should apply wherever you are treated — the criteria are summarised in how to compare providers in Thailand.
Ask Us for the Documentation First
We are happy to walk through sourcing, laboratory standards and release testing before you make any decision about treatment. MRC Healthcare is a physician-led regenerative medicine group in Bangkok.
Schedule a Consultation





